CAD Sciences

CAD Sciences was a medical technology company that specialized in the development of Computer-Aided Detection (CAD) and image analysis software for Magnetic Resonance Imaging (MRI). The company's primary focus was on improving the detection and characterization of breast and prostate cancer through its proprietary Full-Time-Point (fTP) analysis technology. This technology automated the processing of contrast-enhanced MRI studies, providing clinicians with standardized kinetic data and visualization tools to assist in diagnosis. By streamlining the workflow for radiologists, the company aimed to increase the accuracy and efficiency of cancer screenings. In 2008, CAD Sciences was acquired by iCAD, Inc., a leader in advanced image analysis and workflow solutions for the early identification of cancer.